a year ago

GlycanAge Secures $4.2 Million Seed Funding for Personalized Preventative Healthcare

  • GlycanAge, a UK-based biotech startup focused on glycan biomarkers, secured $4.2 million in seed funding led by LAUNCHub Ventures and Kadmos Capital

  • The company plans to utilize the funds for operational expansion and development efforts

  • GlycanAge specializes in glycobiology and biological aging, offering a biological age test for personalized preventative healthcare

  • CEO Nikolina Lauc expressed enthusiasm about the funding, emphasizing the shared vision for a healthier future and the milestone achieved for GlycanAge.

      • ProblemTechnology

      "trying to measure biological age instead of chronological age, without the need for expensive medical tests"

      Solution

      ""

      Covered on